FOLH1 and prostate carcinoma: PET/CT using Prostate Specific Membrane Antigen (PSMA) radiotracer, either radiolabeled with 68Ga or 18F, detects cellular expression of PSMA and is being increasingly used in the staging of prostate cancer patients (31, 32).